These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 28409389)
1. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection. Sharma N; Sharma S; Nehru B Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389 [TBL] [Abstract][Full Text] [Related]
2. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway. Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679 [TBL] [Abstract][Full Text] [Related]
4. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo. Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997 [No Abstract] [Full Text] [Related]
5. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia. Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539 [TBL] [Abstract][Full Text] [Related]
6. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model. Sharma N; Nehru B Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of Intranasal IGF-1 against Neonatal Lipopolysaccharide-Induced Neurobehavioral Deficits and Neuronal Inflammation in the Substantia Nigra and Locus Coeruleus of Juvenile Rats. Tien LT; Lee YJ; Pang Y; Lu S; Lee JW; Tseng CH; Bhatt AJ; Savich RD; Fan LW Dev Neurosci; 2017; 39(6):443-459. PubMed ID: 28787734 [TBL] [Abstract][Full Text] [Related]
8. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats. Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220 [TBL] [Abstract][Full Text] [Related]
9. Diosgenin Prevents Microglial Activation and Protects Dopaminergic Neurons from Lipopolysaccharide-Induced Neural Damage In Vitro and In Vivo. Lee SL; Tu SC; Hsu MY; Chin TY Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638697 [TBL] [Abstract][Full Text] [Related]
10. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation. Wang J; Wu WY; Huang H; Li WZ; Chen HQ; Yin YY Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698 [TBL] [Abstract][Full Text] [Related]
11. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis. Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D Front Immunol; 2018; 9():2527. PubMed ID: 30455692 [TBL] [Abstract][Full Text] [Related]
12. L-alpha-aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson's disease in male rats. O'Neill E; Chiara Goisis R; Haverty R; Harkin A J Neurosci Res; 2019 Jul; 97(7):804-816. PubMed ID: 30924171 [TBL] [Abstract][Full Text] [Related]
13. Tenuigenin protects dopaminergic neurons from inflammation-mediated damage induced by the lipopolysaccharide. Yuan HL; Li B; Xu J; Wang Y; He Y; Zheng Y; Wang XM CNS Neurosci Ther; 2012 Jul; 18(7):584-90. PubMed ID: 22759267 [TBL] [Abstract][Full Text] [Related]
14. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways. Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745 [TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration. Qin L; Liu Y; Hong JS; Crews FT Glia; 2013 Jun; 61(6):855-68. PubMed ID: 23536230 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation. Sharma N; Nehru B Neurochem Int; 2015 Aug; 87():92-105. PubMed ID: 26055970 [TBL] [Abstract][Full Text] [Related]
17. Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide. Kaizaki A; Tien LT; Pang Y; Cai Z; Tanaka S; Numazawa S; Bhatt AJ; Fan LW J Neuroinflammation; 2013 Apr; 10():45. PubMed ID: 23561827 [TBL] [Abstract][Full Text] [Related]
18. n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats. Ji A; Diao H; Wang X; Yang R; Zhang J; Luo W; Cao R; Cao Z; Wang F; Cai T Neurotoxicology; 2012 Aug; 33(4):780-8. PubMed ID: 22406923 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms. Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674 [TBL] [Abstract][Full Text] [Related]
20. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Zhou HF; Liu XY; Niu DB; Li FQ; He QH; Wang XM Neurobiol Dis; 2005 Apr; 18(3):441-9. PubMed ID: 15755670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]